RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
An assessment of Japanese medaka estrogen receptors in vitellogenin induction
Lee Pow, C. S. D., Yost, E. E., Aday, D. D., & Kullman, S. W. (2016). Sharing the roles: An assessment of Japanese medaka estrogen receptors in vitellogenin induction. Environmental Science & Technology, 50(16), 8886-8895. https://doi.org/10.1021/acs.est.6b01968
Teleost fish express at least three estrogen receptor (ER) subtypes. To date, however, the individual role of these ER subtypes in regulating expression of estrogen responsive genes remains ambiguous. Here, we investigate putative roles of three ER subtypes in Japanese medaka (Oryzias latipes), using vitellogenin (VTG) I and II as model genes. We identify specific ligand/receptor/promoter dynamics, using transient transactivation assays that incorporate luciferase reporters comprising 3kb promoter/enhancer regions of medaka VTGI and VTGII genes. Four steroidal estrogens (17 beta-estradiol, estrone, estriol, and 17 alpha-estradiol) were tested in these assays. Results indicate that all three medaka ERs (mERs) are capable of initiating transactivation of both VTG I and II, with ER beta 2 exhibiting greatest activity. Promoter deletion analysis suggests that ligand-specific receptor transactivation and utilization of regional-specific estrogen response elements may be associated with differential activities of each medaka ER Further, cluster analysis of in vivo gene expression and in vitro transactivation suggests that all three ER subtypes putatively play a role in up-regulation of VTG. Results illustrate preferential ligand/receptor/promoter interactions may have direct implications for VTG gene expression and other mediated regulatory functions that are relevant to the risk assessment of estrogenic compounds.